Eupraxia Pharmaceuticals (NASDAQ:EPRX) Trading Up 3.4% - What's Next?

Shares of Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX - Get Free Report) traded up 3.4% during mid-day trading on Friday . The stock traded as high as $2.60 and last traded at $2.40. 5,948 shares were traded during trading, a decline of 60% from the average session volume of 14,952 shares. The stock had previously closed at $2.32.

Eupraxia Pharmaceuticals Trading Up 3.4 %

The stock has a 50 day moving average of $2.59. The stock has a market capitalization of $65.47 million and a price-to-earnings ratio of -2.96.

Eupraxia Pharmaceuticals (NASDAQ:EPRX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.17) earnings per share for the quarter.

Hedge Funds Weigh In On Eupraxia Pharmaceuticals

An institutional investor recently bought a new position in Eupraxia Pharmaceuticals stock. 180 Wealth Advisors LLC bought a new stake in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 13,000 shares of the company's stock, valued at approximately $34,000.

Eupraxia Pharmaceuticals Company Profile

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company's lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee.